237 related articles for article (PubMed ID: 17649812)
21. Expression of inhibin/activin subunits, sialyl-lewis A (CA 19-9, sLea) and sialyl-Lewis X (sLex) carbohydrate antigens in a hydatidiform mole with persistent polymorphic trophoblastic hyperplasia.
Mylonas I; Makovitzky J; Vogel M; Shabani N; Jeschke U; Friese K
Anticancer Res; 2005; 25(3A):1725-30. PubMed ID: 16033091
[TBL] [Abstract][Full Text] [Related]
22. Immunodiagnostic potential of mucin (MUC2) and Thomsen-Friedenreich (TF) antigens in Egyptian patients with colorectal cancer.
El-Sayed IH; Lotfy M; Moawad M
Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):91-7. PubMed ID: 21381504
[TBL] [Abstract][Full Text] [Related]
23. Inhibin/activin subunits are immunohistochemically expressed in complete and partial hydatidiform moles.
Mylonas I; Shabani N; Vogl J; Makovitzky J; Kunze S; Kuhn C; Schulze S; Friese K; Jeschke U
Anticancer Res; 2007; 27(4A):1995-2000. PubMed ID: 17649811
[TBL] [Abstract][Full Text] [Related]
24. Triplet pregnancy with partial hydatidiform mole coexisting with two fetuses: a case report.
Kim CH; Kim YH; Kim JW; Kim KM; Cho MK; Kim SM; Nam JH; Song TB
J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):641-4. PubMed ID: 18840171
[TBL] [Abstract][Full Text] [Related]
25. Morphological, immunohistochemical and chromosome in situ hybridization in the differential diagnosis of Hydatidiform Mole and Hydropic Abortion.
Maggiori MS; Peres LC
Eur J Obstet Gynecol Reprod Biol; 2007 Dec; 135(2):170-6. PubMed ID: 17602823
[TBL] [Abstract][Full Text] [Related]
26. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection.
Kumar SR; Sauter ER; Quinn TP; Deutscher SL
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6868-71. PubMed ID: 16203776
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole.
Thaker HM; Berlin A; Tycko B; Goldstein DP; Berkowitz RS; Castrillon DH; Genest DR
J Reprod Med; 2004 Aug; 49(8):630-6. PubMed ID: 15457853
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of endothelial nitric oxide synthase and C-kit in the placenta of complete hydatidiform mole.
Ahmed A; Lacson A; Gilbert-Barness E
Fetal Pediatr Pathol; 2005; 24(3):141-7. PubMed ID: 16338875
[TBL] [Abstract][Full Text] [Related]
29. [Trophoblastic disease. I. Use of immunohistochemistry in the diagnosis of complete hydatidiform moles].
Danihel L; Porubský J; Zaviacic T; Vojtassák J; Breitenecker G
Cesk Patol; 1994 Aug; 30(3):76-9. PubMed ID: 7923420
[TBL] [Abstract][Full Text] [Related]
30. Utility of p57 protein(KIP2) in molar disease to determine its androgenetic origin.
García-Barriola V; de Gómez MN; Dickson-González S; Figueira L; Cortés-Charry R
J Reprod Med; 2008 Jul; 53(7):476-80. PubMed ID: 18720921
[TBL] [Abstract][Full Text] [Related]
31. p57KIP2 immunostaining in the diagnosis of complete versus partial hydatidiform moles.
Sebire NJ; Lindsay I
Histopathology; 2006 Jun; 48(7):873-4. PubMed ID: 16722940
[No Abstract] [Full Text] [Related]
32. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis.
Mao TL; Kurman RJ; Huang CC; Lin MC; Shih IeM
Am J Surg Pathol; 2007 Nov; 31(11):1726-32. PubMed ID: 18059230
[TBL] [Abstract][Full Text] [Related]
33. The granzyme B inhibitor, PI-9, is differentially expressed during placental development and up-regulated in hydatidiform moles.
Buzza MS; Hosking P; Bird PI
Placenta; 2006 Jan; 27(1):62-9. PubMed ID: 16310039
[TBL] [Abstract][Full Text] [Related]
34. Histopathological diagnosis of hydatidiform mole.
Ockleford CD; Reti LL; Calvert JP; Badley RA
J Pathol; 1983 May; 140(1):51-67. PubMed ID: 6343569
[TBL] [Abstract][Full Text] [Related]
35. [Prenatal diagnosis and clinical management of a twin pregnancy consisting of a complete mole and coexisting fetus].
Qi QW; Xiang Y; Hao N; Liu JT; Xu YH; Yang XY; Sun NH
Zhonghua Fu Chan Ke Za Zhi; 2003 Oct; 38(10):595-8. PubMed ID: 14728860
[TBL] [Abstract][Full Text] [Related]
36. Complete mole coexistent with a twin fetus.
Ogura T; Katoh H; Satoh S; Tsukimori K; Hirakawa T; Wake N; Nakano H
J Obstet Gynaecol Res; 2006 Dec; 32(6):593-601. PubMed ID: 17100822
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.
McConnell TG; Murphy KM; Hafez M; Vang R; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):805-17. PubMed ID: 19145201
[TBL] [Abstract][Full Text] [Related]
38. [Problems in the ultrasonic diagnosis of hydatidiform mole].
Weill F; Heitz P; Fega R; Becker JC
J Radiol Electrol Med Nucl; 1972 Oct; 53(10):697. PubMed ID: 4640530
[No Abstract] [Full Text] [Related]
39. Expression of Fas/Fas ligand by decidual leukocytes in hydatidiform mole.
Wongweragiat S; Searle RF; Bulmer JN
Biol Reprod; 2001 Mar; 64(3):784-9. PubMed ID: 11207192
[TBL] [Abstract][Full Text] [Related]
40. Osteopontin is down-regulated in hydatidiform mole.
Batorfi J; Fulop V; Kim JH; Genest DR; Doszpod J; Mok SC; Berkowitz RS
Gynecol Oncol; 2003 Apr; 89(1):134-9. PubMed ID: 12694667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
